SCHEMBL4375478

SCHEMBL4375478

NNc1nc(C(F)(F)F)ccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.38
GAA P10253 3/20 0.38
P2RX7 Q99572 1/20 0.38
RAB9A P51151 2/20 0.35
MAT2A P31153 2/20 0.35
MEN1 O00255 2/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 2/20 0.34
KMT2A Q03164 2/20 0.34
NT5E P21589 1/20 0.34
HSD17B10 Q99714 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
SYK P43405 1/20 0.32
NPC1 O15118 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GOT1 P17174 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21223004 0.77 MAPT (0.41) MAPTKDM4EALDH1A1GAAP2RX7
SCHEMBL29505062 0.74 MAT2A (0.42) KDM4EALDH1A1P2RX7MAT2AKMT2A
SCHEMBL14955141 0.74 MAT2A (0.42) KDM4EALDH1A1P2RX7MAT2AKMT2A
SCHEMBL4371685 0.73 NT5E (0.39) KDM4EALDH1A1P2RX7MAT2ANT5E
SCHEMBL7024893 0.73 MAPT (0.41) MAPTKDM4EALDH1A1GAARAB9A
SCHEMBL24761059 0.72 TAS2R14 (0.44) MAPTKDM4EALDH1A1GAAP2RX7
SCHEMBL2634744 0.71 NOTUM (0.42) KDM4EALDH1A1MAT2ANT5EHSD17B10
SCHEMBL15284060 0.71 NT5E (0.38) KDM4EALDH1A1MAT2ANT5EHSD17B10
SCHEMBL15294527 0.69 MAPT (0.38) MAPTKDM4EALDH1A1GAAP2RX7
SCHEMBL404271 0.69 KDM4E (0.41) KDM4EGAALMNANT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2831044-B1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES DOW AGROSCIENCES LLC (US) 2020-11-11 EP disclosed
EP-2831044-B1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES DOW AGROSCIENCES LLC (US) 2020-11-11 EP disclosed
CN-104321310-B Process for preparing 3-substituted-6-trifluoromethylpyridines and process for using 6-trichloromethyl halopyridines 陶氏益农公司 2017-02-22 CN disclosed
EP-2831044-A1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES Dow AgroSciences LLC (US) 2015-02-04 EP disclosed
CN-104321310-A Process for preparing 3-substituted-6-trifluoromethylpyridines and process for using 6-trichloromethyl halopyridines DOW AGROSCIENCES LLC 2015-01-28 CN disclosed
US-8785650-B2 Methods for preparing 3-substituted-6-trifluoromethyl pyridines and methods for using 6-trichloromethyl halogenated pyridines DOW AGROSCIENCES, LLC. (US) 2014-07-22 US disclosed
US-8785650-B2 Methods for preparing 3-substituted-6-trifluoromethyl pyridines and methods for using 6-trichloromethyl halogenated pyridines DOW AGROSCIENCES, LLC. (US) 2014-07-22 US disclosed
US-20130261310-A1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES CORTEVA AGRISCIENCE LLC 2013-10-03 US disclosed
US-20130261310-A1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES CORTEVA AGRISCIENCE LLC 2013-10-03 US disclosed
WO-2013148338-A1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES DOW AGROSCIENCES LLC (US) 2013-10-03 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130261310-A1 METHODS FOR PREPARING 3-SUBSTITUTED-6-TRIFLUOROMETHYL PYRIDINES AND METHODS FOR USING 6-TRICHLOROMETHYL HALOGENATED PYRIDINES CYP4F3, CBR3, PRDX6 MAPT 4755/4885KDM4E 1199/4885ALDH1A1 1336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.